Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,137,871 | 1,043,759 | 880,889 | 1,013,341 | 919,025 |
| Cost of Goods | 85,993 | 76,634 | 60,956 | 69,751 | 60,091 |
| Gross Profit | 1,051,878 | 967,125 | 819,933 | 943,590 | 858,934 |
| Operating Expenses | 906,786 | 1,445,889 | 728,991 | 757,071 | 644,320 |
| Operating Income | 146,085 | -478,130 | 91,898 | 187,270 | 214,705 |
| Interest Expense | 774 | 657 | 430 | 804 | 623 |
| Other Income | 11,213 | 89,010 | 144,691 | 84,490 | 19,717 |
| Pre-tax Income | 156,524 | -389,777 | 236,159 | 270,956 | 233,799 |
| Income Tax | 50,068 | 54,824 | 66,611 | 69,877 | 62,530 |
| Net Income Continuous | 106,456 | -444,601 | 169,548 | 201,079 | 171,269 |
| Net Income | $106,456 | $-444,601 | $169,548 | $201,079 | $171,269 |
| EPS Basic Total Ops | 0.55 | -2.04 | 0.76 | 0.90 | 0.76 |
| EPS Basic Continuous Ops | 0.55 | -2.04 | 0.76 | 0.90 | 0.76 |
| EPS Diluted Total Ops | 0.54 | -2.04 | 0.75 | 0.89 | 0.76 |
| EPS Diluted Continuous Ops | 0.54 | -2.04 | 0.75 | 0.89 | 0.76 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.03 | 0.38 | 0.82 | 0.91 |
| EBITDA(a) | $168,605 | $-456,082 | $113,845 | $209,032 | $236,095 |